Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: eye  exam  sight  health  woman  vision  care  cancer  protection  multivu  8363551  natural  remedies  for  insomnia  medicine  family  safety  health  pharmaceuticals  teeth  children  cold  probiotics  multivu  8134881  blink  health  health  healthcare  type  2  diabetes  treatment  medication  money  multivu  8117451  pharmaceutical  company  kaleo  auvi  q  injector  auto  medical  health  healthcare  multivu  7981051  healthcare  health  open  enrollment  medicare  prescription  coverage  insurance  davita  medical  multivu  7920151  photo  social  media  profile  health  overweight  appearance  improvement  treatment  multivu  7962051  health  medication  lawsuit  money  astellas  pharma  prograf  money  refund  healthcare  multivu  7933851  cutanea  life  sciences  technology  dermatologists  health  skin  disorders  doctors  skin  care  multivu  7743651  woman  depression  antidepressant  medication  cdc  disease  health  mental  family  children  multivu  7709851  adlens  adlensfocuss  eyeglasses  eyewear  near  vision  eyesight  eye  multivu  7544851  eyeglass  world  smart  glass  prescription  lenses  eyewear  recon  jet  vuzix  m100  epson  moverio  multivu  7544551 
Search // prescription
Results 1-12 of 41 for ' prescription ' (2 seconds)
Today, VSP Vision Care, the largest not-for-profit vision benefits provider in the United States, and market research agency YouGov released new findings showing that half of people in the U.S. are neglecting their eyes despite 84 percent of people rating vision as their most important sense. This disconnect occurs because people don’t understand the importance of annual eye exams and its connection to overall health. In fact, only 1 percent of people know that signs of serious conditions like thyroid disease, high blood pressure, autoimmune disorders and certain types of cancer can be detected through annual eye exams. This is concerning because even if you have naturally good vision and don’t need prescription glasses, you still need an annual eye exam to protect your overall health. To view the multimedia release go to: https://www.multivu.com/players/English/8363551-vsp-vision-care/
Categories // Miscellaneous 
Added: 46 days ago by MultiVuVideos
Runtime: 1m6s | Views: 5 | Comments: 0
Not yet rated
 

 

 

In this video we'll talk about a natural sleep remedy that is so effective it just might save you from prescription sleeping pills and their unwanted side effects. https://www.youtube.com/watch?v=t4YlBrHyROQ
Tags // natural  remedies  for  insomnia 
Categories // Miscellaneous 
Added: 296 days ago by johngeltkn
Runtime: 3m16s | Views: 2 | Comments: 2
Not yet rated
 

 

 

Blink Health, America’s leading prescription drug savings platform, today launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of medication to patients with type-2 diabetes. People living with diabetes who create an account on Blink Health’s website or free mobile app, starting today, will receive a free, one-year supply of the three most commonly prescribed generic medications for type-2 diabetes: metformin, glipizide and pioglitazone. The program will also cover these three medications for existing Blink Health patients who use them. To view the multimedia release go to: https://www.multivu.com/players/English/8117451-blink-health-type-2-diabetes-medications/
Categories // Miscellaneous 
Added: 494 days ago by MultiVuVideos
Runtime: 0m15s | Views: 5 | Comments: 0
Not yet rated
 

 

 

Kaléo, a privately-held pharmaceutical company, today announced the AUVI-Q® (epinephrine injection, USP) Auto-injector will be available by prescription starting February 14th, and announced AUVI-Q AffordAbility, a first-of-its-kind access program for AUVI-Q. Through this new program, patients with commercial insurance, even those with high-deductible plans, will have an out-of-pocket cost of $0. For patients who do not have government or commercial insurance, and have a household income of less than $100,000, AUVI-Q will be available free of charge. In addition, the cash price for AUVI-Q is $360 and will be available to those patients without government or commercial insurance. Each AUVI-Q prescription includes two Auto-injectors and one Trainer for AUVI-Q. To view the multimedia release go to: http://www.multivu.com/players/English/7981051-auvi-q-epinephrine-auto-injector-access-and-availability-launch/
Categories // Miscellaneous 
Added: 634 days ago by MultiVuVideos
Runtime: 3m17s | Views: 7 | Comments: 0
Not yet rated
 

 

 

HealthCare Partners, a division of DaVita Inc. (NYSE: DVA), a leading independent medical group in the United States, is encouraging Medicare beneficiaries to review their health care coverage during Medicare’s Open Enrollment Period. From October 15 through December 7, Medicare holds its annual Open Enrollment Period. During this seven-week window, Medicare beneficiaries can make changes to their health and prescription drug plans for the following year. If you are satisfied with your Medicare coverage, you may wonder how open enrollment applies to you. As the old adage goes, “if it isn’t broke, don’t fix it,” right? While this may certainly be the case for many things in life, it may not be true about your Medicare coverage. Choosing a Medicare plan is similar to shopping for other insurance; by comparing different plans and rates, you choose the coverage that’s best for you. To view the multimedia release go to: http://www.multivu.com/players/English/7920151-healthcare-partners-medicare-open-enrollment/
Categories // Miscellaneous 
Added: 696 days ago by MultiVuVideos
Runtime: 2m29s | Views: 51 | Comments: 0
Not yet rated
 

 

 

Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best. Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo. To view the multimedia release go to: http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
Categories // Miscellaneous 
Added: 720 days ago by MultiVuVideos
Runtime: 3m40s | Views: 60 | Comments: 1
Not yet rated
 

 

 

The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation. A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing. To view the multimedia release go to: http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
Categories // Miscellaneous 
Added: 720 days ago by MultiVuVideos
Runtime: 0m30s | Views: 58 | Comments: 0
Not yet rated
 

 

 

Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV). CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services. To view the multimedia release go to: http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
Categories // Miscellaneous 
Added: 952 days ago by MultiVuVideos
Runtime: 1m44s | Views: 160 | Comments: 0
Not yet rated
 

 

 

More than 15 percent of reproductive-aged women have filled a prescription for an antidepressant medication during the years 2008–2013, according to a new analysis published today in the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR). January is National Birth Defects Prevention Month and the CDC is working with the March of Dimes to raise awareness about the use of antidepressant medications by women of reproductive age, and what women should know and do for their own health and that of their babies. There is conflicting evidence about the potential link between some antidepressants and certain birth defects. Some commonly used antidepressants are sertraline (Zoloft), bupropion (Wellbutrin, Zyban), and citalopram (Celexa). To view the multimedia release go to: http://www.multivu.com/players/English/7709851-march-of-dimes-antidepressant-pregnancy-study/
Categories // Miscellaneous 
Added: 991 days ago by MultiVuVideos
Runtime: 1m31s | Views: 263 | Comments: 0
Not yet rated
 

 

 

Adlens, the global leader in adjustable focus eyewear, has launched its ground-breaking adjustable prescription eyewear ‘AdlensFocuss™’, the greatest advancement in optics in more than 50 years. Vision inevitably changes with age and people often need different strength glasses to see at near, intermediate and far distances. Progressive lenses are an option but they have a restricted usable lens area. A GFK Roper Study has shown one-third of wearers say they have trouble adjusting to them with seven to eight percent of wearers saying they cannot adjust to them at all. AdlensFocuss provides the benefits of a single vision lens – full frame viewing area – with the best features of a progressive lens – the ability to see at different distances. They are prescription glasses with proprietary technology; a unique flexible membrane that allows the power to be adjusted by simply turning small dials on the inside of the frames. AdlensFocuss lenses offer at least four times more viewing area than traditional progressive lenses and come encased in a fashion-forward frame from award-winning designer Blake Kuwahara. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7544851-adlensfocuss-optics-technology/
Categories // Fashion and Lifestyle 
Added: 1195 days ago by MultiVuVideos
Runtime: 2m32s | Views: 324 | Comments: 3
Not yet rated
 

 

 

Eyeglass World®, a leading retailer of affordable prescription eyewear, is the first national chain to launch a retail collection of prescription lenses for smart glass technologies in the U.S. The debut of specially designed prescription lens options for wearable brands including Glass, Recon, Vuzix and Epson coincides with Eyeglass World’s retail expansion into California. On Friday, the company celebrated the grand opening of a Vista, California location – the first of eight Eyeglass World stores planned for the San Diego area by June 2016. To view the Multimedia News Release, go http://www.multivu.com/players/English/7544551-eyeglass-world-expands-debuts-smart-glass/
Added: 1210 days ago by MultiVuVideos
Runtime: 1m43s | Views: 264 | Comments: 3
Not yet rated
 

 

 

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP). To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Added: 1273 days ago by MultiVuVideos
Runtime: 3m35s | Views: 257 | Comments: 2
Not yet rated
 

 

 

Page 1 of 4  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 ClipMoon.com. All rights reserved.